Charles Schwab Investment Management Inc. Raises Stock Holdings in Sarepta Therapeutics, Inc. (NASDAQ:SRPT)
Charles Schwab Investment Management Inc. boosted its holdings in Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 2.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 623,749 shares of the biotechnology company’s stock after acquiring an additional 12,000 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Sarepta Therapeutics were […]
Charles Schwab Investment Management Inc. boosted its holdings in Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Free Report) by 2.0% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 623,749 shares of the biotechnology company’s stock after acquiring an additional 12,000 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Sarepta Therapeutics were […]
